📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. (2023)

First Author: Moosa MS

Attributed to: MICA: Applying innovative technologies to improve benefit-risk ratio of drugs: developing a national resource underpinned by the MRC Centre for CDSS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15661

PubMed Identifier: 36639145

Publication URI: http://europepmc.org/abstract/MED/36639145

Type: Journal Article/Review

Volume: 89

Parent Publication: British journal of clinical pharmacology

Issue: 6

ISSN: 0306-5251